Skandinaviska Enskilda Banken AB (publ) - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$506
-33.3%
11,000
-16.7%
0.00%
-40.0%
Q2 2023$759
-99.9%
13,200
-64.1%
0.01%
+25.0%
Q1 2021$674,000
-8.9%
36,8000.0%0.00%
-20.0%
Q4 2020$740,000
-34.7%
36,800
-39.1%
0.01%
-37.5%
Q3 2020$1,133,000
-16.5%
60,4000.0%0.01%
-27.3%
Q2 2020$1,357,000
-53.5%
60,400
-69.3%
0.01%
-26.7%
Q1 2020$2,918,000
+99.6%
196,600
+159.4%
0.02%
+36.4%
Q4 2019$1,462,000
-21.7%
75,800
-19.5%
0.01%
-31.2%
Q3 2019$1,868,000
-14.1%
94,200
-8.5%
0.02%
-15.8%
Q2 2019$2,174,000
-9.2%
103,000
-12.1%
0.02%
-13.6%
Q1 2019$2,394,000
+2.2%
117,200
-0.4%
0.02%
+4.8%
Q4 2018$2,342,000
-20.1%
117,700
-22.7%
0.02%
-4.5%
Q3 2018$2,930,000
+34.2%
152,300
+6.4%
0.02%
+15.8%
Q2 2018$2,184,000
-6.3%
143,100
+15.1%
0.02%
-13.6%
Q1 2018$2,331,000
-12.9%
124,300
-10.6%
0.02%
-4.3%
Q4 2017$2,676,000
-13.5%
139,100
-19.6%
0.02%
-17.9%
Q3 2017$3,092,000
-5.1%
173,000
-5.2%
0.03%
-9.7%
Q2 2017$3,258,000
-48.1%
182,400
-57.9%
0.03%
+3.3%
Q1 2017$6,282,000
+95.8%
433,200
+148.7%
0.03%
-23.1%
Q4 2016$3,209,000
-21.2%
174,200
-18.8%
0.04%
-11.4%
Q3 2016$4,071,000
+3.2%
214,600
-12.3%
0.04%0.0%
Q2 2016$3,946,000
+34.3%
244,8000.0%0.04%
+33.3%
Q1 2016$2,938,000
-27.3%
244,800
-13.8%
0.03%
-36.5%
Q4 2015$4,041,000284,0000.05%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders